Abstract: Regulatory changes in the pharmaceutical industry have recast the role of chemical engineering in the development of processes for the large-scale manufacture of Active Pharmaceutical Ingredients. Health authorities' expectations have increased regarding proven demonstration of adequate process performance, process robustness, and quality control across development and manufacturing scales. These expectations have substantially increased the demands of experimental data collection, process monitoring, and multivariate process understanding. To address these requirements, innovative implementation of established and emerging automation, modeling, data management, and process monitoring techniques have been increasingly added to the repertoire of process development tools in particular, those carried out in agitated stirred tanks. This article will introduce the application of these techniques across the range of process development (from early to late phase) challenges. In particular, this article describes the implementation of Data Exploration Analysis to results obtained with automated parallel experimentation for batch reaction characterization and automated batch crystallization processes integrated to population balance modeling. Collectively these examples of new strategies for the automation of experimental batch processes, data analysis, and modeling provide an overview of recent trends in pharmaceutical chemical process development.
INTRODUCTION
Engineering research and development in the pharmaceutical industry is experiencing two significant change agents-one is being driven by a substantial revision of the expectations of process knowledge and robustness from the regulatory agencies, and the other by the massive influx of automation, parallel experimentation, and availability of digital data. On the regulatory front, the Quality by Design formalism introduced by health authorities and codified in The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines sets out specific requirements on the expected level of process understanding, robustness, and control associated with the manufacture of the Active Pharmaceutical Ingredient (API). Inherent to this formalism is the notion of Quality by Design whereby the "quality" of the drug product is "designed" into the process. The regulatory expectations may not have changed the way in which pharmaceutical process and development is conducted but they have had a significant impact on the way in which models and quantitative process risk assessment are documented, presented, and integrated into the regulatory filing process.
The industry has responded to these requirements by incorporating increased mathematical rigour and leveraging large datasets with novel chemometric approaches (GarciaMunoz et al., 2010) . Peterson et al. (2008) have studied the incorporation of Bayesian statistics to quantitatively determine the risk associated with the control strategy of manufacturing processes. These works have significantly enhanced the role of statistics in pharmaceutical research and development.
This paper presents case studies that collectively provide an overview of how these two forces continue to be transformative agents in chemical engineering process research and development. In particular we discuss the development and characterization of two unit operations that are at the core of chemical pharmaceutical manufacturing, namely, batch crystallization and batch chemical reactions.
Despite notable technical advances in continuous technology, a large portion of the available chemical infrastructure in the pharmaceutical and fine chemical space in established and emerging markets is dominated by the prevalence of agitated tanks. In addition, the typical organic synthetic laboratory development is conducted in scaled-down batch reactors in which the synthesis of the API is achieved by a series of sequential or convergent chemical transformations. In sequential batch processing, the quality attributes of a pharmaceutical product are established by integral contributions from the complete process train. Therefore, implementation of a Quality by Design strategy is largely facilitated by having a comprehensive model for each synthetic step in the manufacture of the API.
Experience at Bristol-Myers Squibb is used to provide a cogent picture of how the increased availability of electronic data, in concert with a regulatory environment expecting knowledge-rich processing information, which has resulted in an increased utilization of Data Exploration Analysis and data visualization techniques to increase the efficiency associated with process development, process evaluation, robustness characterization, risk assessment, and parameter control. An integral component to this exposition is the increasingly powerful role that automation technologies has achieved over the past few decades and its corresponding influence on all aspects of process design including rapid process characterization with parallel experimentation, and the development of the final crystallization of the API.
BATCH REACTION
From a regulatory perspective, chemical purity is the most important quality attribute of the API and is strongly dictated by the chemical synthesis utilized in the manufacturing process. Therefore, the reactive chemical transformations that detail the individual components of the synthesis are of key importance and require accurate quantitative characterization. Invariably a key goal of the chemical development process is to develop a mechanistic model that precisely explains all the chemical transformations for the substrate and all related input impurities. This model can subsequently be used to optimize the reaction conditions and determine the sensitivity of the reaction to process parameter variability, i.e., it provides the basis for quantitative risk assessment of the process.
Adequate design of extractions, crystallizations, and other purification strategies are routinely employed to ensure the chemical purity of the API, however, removing reducing or eliminating the formation of impurities in the reaction stream by controlling the selectivity of the reaction is the preferred approach for quality control. The experimental burden associated with a quantitative characterization of the reaction can be addressed by selective implementation of automated parallel workflows. Guzikowski et al. (2010) demonstrated a formalism using Data Visualization Techniques and statistical analysis to analyze results from automated parallel experimentation and reduce the dimensionality of the data required to characterize a chemical reaction in the synthesis of an active product ingredient. In this work the batch-operated biphasic reaction in Scheme 1 was studied. The desired product in this synthetic step exhibits a propensity to racemize and form the enantiomer impurity. In addition, base-catalyzed reactions also generate an additional three impurities that are denoted as imine, sulfone, and dialkylated sulfone.
As it is becoming a more routinely applied procedure in research and development, this work incorporated sequential fractional factorial design of experiments (DOEs) to study the impact on the reaction kinetics for product and impurity formation. The parameters thought to contribute to reaction performance were (1) temperature, (2) reaction concentration, (3) equivalents of BB, (4) equivalents of base, (5) equivalents of phase transfer catalyst (PTC), (6) agitation level, and (7) amount of water present in the reactor (a potential contaminant or variable in the reagents). The multivariate space for this study is typical of those generally encountered in pharmaceutical organic synthesis. An advantage of batch reactions in organic synthesis is that the charging operation is isolated from the reaction by reaching isothermal reaction temperature after all the charges have been completed. In this sense, the process may be readily adapted to a fairly standardized high throughput automation platform. In the work described by Guzikowski et al. (2010) a SYMYX system was used to execute the sequential DOEs. The data output from the workflow rapidly grew to a relatively large dataset maintained in a Laboratory Execution and Analysis System (LEA). To enhance the conventional statistical analysis that would include a number of summary statistics, Pareto plots, and surface response regression, this work incorporated techniques from data visualization analysis to draw inferences directly from the experimental data set. Heat maps, such as the one shown in Figure 1 were used to demonstrate visually the main effects (in the case of Figure 1 temperature of the reaction) on the rate of formation of the enantiomer impurity and the rate of decay of the starting material during the reaction. In the ranges studied, temperature was the most significant parameter (p = 0.001) on the reaction kinetics towards starting material conversion and enantiomer impurity formation an effect that is clearly observable on both the profiles for the starting material and the enantiomer impurity.
Naturally, there were similar graphs for the other 3 impurities in all seven factors for a total of 35 graphical representations which are not shown here. The impact of the reaction parameters on the reaction kinetics or conversion of the starting material (measured by HPLC-AP) and formation of all the impurities could then be visualized easily long with their corresponding significance value. However, a general problem in the characterization of reactions is that (as in this case) the quality of the reaction is represented by five responses (remaining level of starting material, and the level of four impurities). Generally the risk assessment of a reaction step would include detailed knowledge on the formation of all the relevant impurities in the step. It is desirable to reduce the characterization and modelling burden by decreasing the material dimensionality of the problem. Using techniques from exploratory data analysis on the complete dataset, it was determined that the impurities were highly correlated ( Figure  2 ). In this case the heat maps were selected to correspond to the parameter with the highest impact on the correlation.
From the graphical projections it was then a straightforward procedure to treat the enantiomer impurity as a "dominant" impurity whose control would automatically imply control of the other impurities below a certain level, in this case it is evident that controlling the enantiomer at a level below 2.5 HPLC-AP in the reaction would result in an corresponding control of the imine, sulfone, and dialkylated sulfone impurities below 2.0, 1.1, and 1.0 HPLC-AP respectively, values that did not represented a quality risk for the downstream isolation. As this correlation was valid in for a well-designed DOE, the risk of a combination of parameters under which deviations from the underlying correlation would be observed is relatively improbable. This dimensionality reduction on the performance of the reaction effectively reduced the five-dimensional problem to that of tracking two responses: starting material conversion, and enantiomer impurity formation.
Visualization of the risk associated with the selected ranges for the parameter was addressed by projecting the two main responses against each other, i.e., enantiomer level vs. reaction conversion. In this representation high selectivity is associated with flat lines close to the x-axis. Figure 3 shows examples of selectivity maps with projected reaction parameters.
The starting material in this reaction was considered a potential impurity that could be easily managed in downstream purification by controlling the level in the reaction to less than 1.0 HPLC-AP. As discussed earlier the enantiomer impurity had a desired control level of less than 2.5 HPLC-AP. These two levels defined the target endpoint for any reaction as somewhere in the box defined by blue limit lines in the lower left quadrant on the graphs. In regulatory parlance, this box is identified as the "design space" for the process.
In the projections shown in Figure 3 , it is clear that decreasing the temperature and increasing the level of BB increases the reaction robustness (low production of enantiomer impurity at all levels of conversion). All reactions conducted at high temperature and low levels of BB failed to reach the desired conversion below the desired limit for the enantiomer impurity (they trend outside the design space). This information is difficult to extract from conventional kinetic curves shown in Figure 1 .
The preferred choice to manage the risk assessment and control definition of a reaction is to develop a mechanistic model. In the work presented here, a surface response model incorporating main, cross, and quadratic effects was developed using genetic algorithms . The model had reliable predictive power for both the reaction conversion and the enantiomer formation rates as a function of all the parameters incorporated in the study.
One aspect of the Quality by Design initiative is that the process knowledge (which, as in this work, generally takes the form of a model) from which the quality control systems are derived should to be represented in a visually accessible format with reduced cognitive requirements. This challenge is present independent of the nature of model used in the unit operation under consideration. Figure 3 . Selectivity graphs for the batch reaction projecting the impact of two major (reaction temperature and level of BB/DIN) and one minor (phase transfer catalyst) variables. Guzikowski et al. (2010) visualized the risk of a multidimensional model by tailoring the data visualization strategy to the audience charged with making the risk management decisions associated with final process definition. In the first approach, virtual DOEs incorporating various ranges over all parameters were used to establish the desired operating conditions for the process. The impact of the parameters was again visualized with a heat map and the predicted reaction profiles were presented on the selectivity (enantiomer level vs. reaction conversion) graphs. Figure 4 shows an example of the type of data visualization analysis described in Guzikowski et al. (2010) for two of the five parameters.
STARTING MATERIAL ENANTIOMER IMPURITY
This type of visualization is iteratively used to collectively determine an optimal set of ranges that adequately conformed to the batch control strategy (ability to control a parameter at manufacturing scale) relative to the probability of not meeting the desired control specification (that is, falling outside the design space). The projection in Figure 4 is a useful graphical strategy to optimize the process ranges in situations where multiple key decision makers have significant expertise based on prior operational experience that would be difficult to codify as a multivariate search algorithm. Once the limits of the operating ranges have been defined, the end result needs to be represented in a more conventional visualization instrument. Historically, 2D projections of 3D plots in which the main response is represented as a function of two variables are the method of choice for widespread dissemination of the design space. These projections are limiting in cases in which the non-represented parameters may impact the response considered. To address this limitation, Guzikowski et al. (2010) floated the parameters excluded from the x-y choice so as to provide the best and worst case surfaces that are accessible from the x-y domain represented, with the resulting surface response curves are shown in Figure 5 . In this case, the desired control at the normal operating ranges for BB level and reaction temperature was 1.2-1.3 8th IFAC Symposium on Advanced Control of Chemical Processes Furama Riverfront, Singapore, July 10-13, 2012 equivalents and 45-60°C with a target operating value at 1.25 equivalents of BB at 50°C. From a regulatory perspective a desired outcome of the process development work is the demonstration of robustness at large-scale. The results from the large-scale verification of the selected control strategy are shown in the circles in Figure 5 .
The work described in this development is typical of the general approach used to characterize reaction performance in particular with respect to the potential impact of impurity formation (reaction selectivity). Increased reliance on automation as a tool for improving productivity will result in a corresponding increase in the size of the datasets associated with reaction characterization. In addition, the underlying models used to predict reaction performance take into account the intrinsic multivariate nature of the process. Therefore, implementation of data visualization significantly aids the development of a control strategy and its subsequent accessible representation.
BATCH CRYSTALLIZATION
A desirable strategy to control the final quality of the API is to eliminate the formation of impurities during the synthetic reactions utilized in the production. Typically however, this approach is nearly impossible to follow consistently. As a result, the crystallization is a logical unit operation to enhance the purity following a synthetic conversion.
The final crystallization in the API synthesis gains particular significance as an isolation point since it determines the powder properties of the isolated API. These properties have a substantial impact in the manufacture of the formulated compound and potentially in the in vivo performance of the active. Although techniques are in place to modify the powder properties of the API following the final crystallization (such as dry-milling and sieving), it is desirable to design the API crystallization to provide the desired properties without further processing. In cases in which the API is dissolved as part of the formulation process, the API would still be expected to meet chemical purity and provide favourable properties (e.g. flow, bulk density, particle size distribution, and crystal habit) for the safe and efficient downstream processing.
The particle size distribution at the completion of a batch crystallization process is characterized by a combination of mechanisms (growth, secondary nucleation, agglomeration, particle breakage, etc.) that take place at every point of the crystallization. A generally accepted guideline (Mersmann, 1995) is to maintain the level of supersaturation (the driving force for most of these mechanisms) relatively consistent over the course of the crystallization process. In batch crystallization, a sharp increase in the level of supersaturation is generally followed by a secondary nucleation event (in cases in which the slurry is already formed) with a potential to impact the final particle size distribution (PSD). Even if the resulting effect on the PSD is desired, uneven excursions in the level of supersaturation in batch crystallization are highly undesirable as they generally result in scale sensitivity since secondary nucleation events are notoriously sensitive to the local shear experienced by the slurry. Nyvlt's pioneering work in modelling batch crystallizers concluded that under certain conditions a cubic temperature profile was optimal for temperature driven crystallizations (Nyvlt, 1971) . Inasmuch as those assumptions (solubility as a function of temperature, growth as a function of size, etc.) do not correspond to the system under study, a cubic temperature (or anti-solvent) addition profile may not result in the optimal crystallization process. It is therefore preferred to either obtain the solubility vs. time profile that is most adequate for a given process experimentally or in the best case, control the crystallization to ensure that the supersaturation remains constant.
Over the past decades, supersaturation control of crystallization has been demonstrated in the laboratory scale for a number of crystallization systems, largely involving temperature driven crystallizations (Feng and Berglund, 2002; Fujiwara et al., 2002; Togkalidou et al., 2001 Togkalidou et al., , 2002 Liotta and Saberson, 2004) . More recently, Rogers et al. (2010) and Vernille et al. (2010) demonstrated the successful implementation of a laboratory system designed to provide automated supersaturation (absolute and relative) control during batch crystallizations.
The automated platform (schematically shown in Figure 6 ) used an ATR-FTIR in situ probe to obtain an estimate of the supernatant concentration of the substrate during the crystallization. The solubility is determined using the temperature and solvent composition of the crystallizer with a previously determined solubility function for the substrate. The feedback loop controls the anti-solvent dosing or temperature required to reach the solubility that at the measured concentration will provide the desired level of supersaturation. The noise from the concentration measurement is addressed by ensuring the steps are unidirectional, i.e. after a change in solvent composition and temperature towards lower solubility the controller waits for the crystallizer to reach that point, a concentration measurement that results in higher supersaturation than desired does not elicit a correction from the controller. This logic is implemented from knowledge that the direction of the concentration in a supersaturated crystallizer is categorically towards lower concentration. Figure 7 shows the resulting concentration and solubility profiles (relative to the set point that would result in constant relative supersaturation) for a driven crystallization in which anti-solvent is added to decrease the solubility of the substrate. In this process the seed which initiated the de-saturation is added at 45% relative supersaturation, with the control algorithm engaging after sufficient desaturation has been achieved (approximately 40 minutes following seeding). As anticipated, constant relative supersaturation (RSS) control results in a gradual rate of mass deposition. The lower figure shows the actual rate of anti-solvent addition fitted to a cubic polynomial. Although consistent with Nyvlt's proposal it is unlikely that without involving a control algorithm the terms of the polynomial would be accessible experimentally.
The cooling portion of the crystallization control was subsequently implemented in a kilo-facility incorporating a MONARC FTIR device programmed with the appropriate calibration model . The MONARC was programmed to send the concentration estimate to the distributed control system (DELTA-V) which subsequently determined the set-point temperature for the batch crystallizer in a similar mode as the laboratory implementation.
The pilot implementation was demonstrated in a temperature driven crystallization and the results for the solubility, supersaturation and concentration profiles as a function of temperature are shown in Figure 8 . In this case the seed was present as equilibrated slurry at the onset of the crystallization, and the control system searched for the appropriate supersaturation level by cooling and decreasing the substrate solubility faster than the rate of mass deposition from the growth of the crystal solid phase. Figure 8 . Concentration, solubility, and operating line for a 100 % target RSS in a crystallization carried out in a 100 L agitated tank in a kilo-lab facility.
In addition to the streamlined development that is afforded from automated batch crystallization control, the data from constant relative supersaturation experiments can be used to perform a regression of the parameters from a population balance crystallization model. Data from temperature driven crystallizations at 50 and 75% relative supersaturation with seed loading from 10-30% were used to fit the growth and secondary nucleation parameters in a population balance model using only the substrate concentration (Rasche et al., 2011) . These results showed that a well-known "fact" in the literature that solute concentration measurements do not provide sufficient information to estimate both secondary nucleation and growth kinetics (e.g., Miller and Rawlings, 1994) , does not hold for all crystallizations. In particular, most pharmaceutical crystallizations operating at the laboratory scale can be operated at sufficiently low supersaturations that the amount of nucleation is negligible during the experiments, in which case the growth kinetics can be estimated in isolation (e.g., see the experimental designs of Kee et al., 2011) . Then the nucleation kinetics can be estimated in subsequent set of experiments that operate at high enough supersaturation to induce secondary nucleation. In an application of this approach, the population balance model adequately predicted higher secondary nucleation for the crystallization under 75% RSS and 30% seed load-a prediction that was consistent with the final isolated material (Rasche et al., 2011) . engineering pharmaceutical research and development. Increased availability of electronic data will continue to challenge the field and drive the adoption of chemometric techniques aimed at enhancing knowledge extraction from increasingly larger and more nuanced datasets. Models developed to predict the quality from chemical unit operations are anticipated to allow for efficient and fast risk analysis; however, the multivariate nature of these processes requires that the results be accessible for evaluation by a diverse technical audience and need to be represented in formats wherein the inferences are readily recognized. Techniques of data visualization allow for knowledge extraction with limited data transformation, and by relying in the structures of the original dataset minimize the possibility of aberration or distortions of the underlying phenomenological dynamics of the process. As the regulatory environment continues to evolve the process of risk management and process definition is anticipated to incorporate an expanding and increasingly diverse audience. To address the challenges associated with knowledge sharing of complex multivariate process the chemical engineer will be required to continually borrow from and adapt techniques from data science and data visualization.
